Early Look: (NASDAQ:COSM) Added to Tomorrow’s Watchlist — See Why We’re Watching

Early Look: (NASDAQ:COSM) Added to Tomorrow’s Watchlist — See…

*Sponsored

Don’t miss the next breakout — get real-time alerts sent straight to your phone!

Market Maven Insights Announces Coverage On Cosmos Health Inc. (NASDAQ:COSM) Starting Tomorrow Morning—Thursday, October 30, 2025

Several Factors Could Be Fueling (COSM)’s Setup — Here’s What You Should See Tonight:

Tight Float: (COSM)’s public float is approx. 20.3M shares — Low Enough to See The Potential For Big Moves If Demand Begins To Shift.

Global Expansion: Expanding its Sky Premium Life® line into the U.S., Kuwait, and Oman, part of a $1T+ nutraceutical market.

AI Innovation: Leveraging its Cloudscreen® AI platform for research on obesity and diabetes formulations.

Digital-Asset Milestone: (COSM) announced it purchased an additional $200,000 of E-T-H-er-eum (E-T-H) under its previously announced $300M digital-assets facility, bringing its total E-T-H holdings to $2M.

Pull Up (COSM) Before Tomorrow Morning…

October 29, 2025

(NASDAQ:COSM) Just Hit Our Watchlist — Here’s Why It’s Gaining Attention

Dear Reader,

Every once in a while, a small-cap name starts rewriting its own story, not through hype, but through execution.

That’s what’s happening right now with Cosmos Health Inc. (NASDAQ:COSM), a global healthcare and wellness group that’s quietly transforming from a traditional nutraceutical distributor into a diversified, tech-enabled health company.

(COSM) is around $1.02 per share with a market cap near $31M, (COSM) remains under Wall Street’s radar, but its actions suggest a company thinking much bigger.

This year (COSM) reported a 53.7% jump in gross profit for Q1 2025 — rising to $2.05M, while cutting its operating cash burn by more than 90%!

That efficiency push brought (COSM) to the edge of cash-flow breakeven, signaling a potential turning point in its operating model.

But what’s really turning heads is COSM’s forward-thinking expansion strategy.

The company secured a $300M E-T-H-er-eum-backed fin-an-cing facility to launch a digital-asset treasury, one of the first of its kind for a healthcare firm. The move aims to leverage block-chain innovation and E-T-H staking for additional balance-sheet strength and shareholder value creation.

At the same time, (COSM) continues scaling its Sky Premium Life® and Mediterranation® brands across the U.S., Kuwait, Oman, and Europe, tapping into a global nutraceuticals market projected to exceed $1T within the decade.

With a public float near 20.3M shares, growing fundamentals, and an unconventional digital-fin-ance strategy driving curiosity, (COSM) is building a narrative that blends health, technology, and innovation, a mix that can move fast when attention shifts.

Inside Cosmos Health (NASDAQ:COSM): Building a Global Wellness Platform

Cosmos Health Inc. (NASDAQ:COSM) is a diversified healthcare groupheadquartered in Chicago, Illinois, operating across pharmaceuticals, nutraceuticals, and medical technology. Through its network of subsidiaries, the company develops, manufactures, and distributes branded health and wellness products to more than a dozen international markets spanning Europe, North America, the Middle East, and Asia.

At the center of (COSM)’s operations are its fully owned subsidiaries, SkyPharm, CosmoFarm, Cana Laboratories, Decahedron, and ZipDoctor, which collectively form an integrated value chain that spans research, production, and retail distribution.

Key Business Divisions

Pharmaceutical Manufacturing & Distribution:
(COSM) produces prescription and OTC dr-ugs under strict European Medicines Agency (EMA) standards at its Cana Laboratories facility in Greece. It also distributes third-party pharmaceuticals to hospitals, clinics, and pharmacies throughout Europe.
Nutraceuticals & Consumer Wellness:
(COSM)’s flagship brands — Sky Premium Life®, Mediterranation®, bio-bebe®, C-Sept®, and C-Scrub® — are now stocked in over 2,000 retail locations and featured on platforms such as Amazon and Holland & Barrett, positioning (COSM) in a global wellness market projected to exceed $1T by 2032.
AI-Enabled R&D & Digital Health:
(COSM) leverages its proprietary Cloudscreen® AI platform for data-driven formulation research targeting major health challenges such as obesity, diabetes, and can-cer. This integration of technology and wellness aims to strengthen product innovation and accelerate clinical validation.
Telehealth Expansion via ZipDoctor:
Through its ZipDoctor subsidiary, (COSM) provides affordable telemedicine services, further expanding its reach into the fast-growing digital health market.

Company Presentation

Scaling for Growth: What’s Next for COSM

COSM (Cosmos Health Inc.) recently reported full-year 2024 revenue of $54.43M, up 2% from the prior year. On the balance sheet side, the company shows $54.31M in total assets as of December 31, 2024.

Looking ahead, (COSM) is targeting at least $155M in annual revenue and $30M in Adjusted EBITDA by 2027—which suggests the business is stepping into a higher gear over the next two years.

With a GMP-certified manufacturing license, GDP-certified distribution network, and a foundation in both consumer wellness and pharmaceuticals, the company is building multiple engines of growth.

If these targets are hit, the current valuation may look modest, offering potential upside if execution aligns.

5 Potential Catalysts Putting (NASDAQ:COSM) On Our Radar Right Now

1. E-T-H-er-eum Treasury Expansion: (COSM) recently completed its initial $1M E-T-H purchase under a $300M digital-asset facility and plans to continue scaling holdings through 2025 — a first-of-its-kind strategy for a healthcare firm.

2. U.S. Manufacturing Ramp-Up: (COSM)’s new “Made-in-America” partnership with DolCas Biotech (NJ) opens U.S. production and distribution channels for its nutraceutical brands, reducing reliance on imports and improving margins.

3. Growing Brand Footprint: (COSM) continues expanding Sky Premium Life® and Mediterranation® products across Europe, the Middle East, and North America, markets feeding into a $1T+ global nutraceutical market.

4. AI-Driven Product Development: Through its Cloudscreen® AI platform, (COSM)is advancing research for obesity and diabetes formulations, areas that could attract future licensing or joint-venture partnerships.

5. Potential Uplisting and Institutional Visibility: With improving fundamentals and expanding international operations, (COSM) could pursue a future uplisting or institutional coverage push to enhance liquidity and market exposure.

The company’s consistent quarter-over-quarter performance improvement, including a 54% gross profit increase and 95% reduction in cash burn, positions it to meet the thresholds that attract many strategic partners.

Pull Up (COSM) Before Tomorrow Morning…

With a public float of roughly 20.3M shares, Cosmos Health Inc. (NASDAQ:COSM)remains one of the tighter healthcare names on the market, a setup that often magnifies reactions when attention shifts.

Following a sharp move earlier this year, nearly 200% in less than three weeks (COSM)continues to attract momentum, interest, supported by strong Barchart technical ratings currently showing an 88% Buy consensus.

But the story now goes well beyond the chart. (COSM) is scaling its Sky Premium Life® and Mediterranation® wellness lines into Kuwait, Oman, and the U.S., entering a global nutraceuticals market projected to surpass $1T by 2032.

Meanwhile, its Cloudscreen® AI platform continues advancing next-generation formulations for obesity, diabetes, and immune support, blending science and technology to build long-term value.

Backed by a solid balance sheet, a $300M E-T-H-er-eum-based treasury program, and management that has personally invested more than $17M into the company, (COSM) is evolving from a niche small-cap into a globally positioned health-tech innovator.

We’ll be watching (COSM) closely into tomorrow’s session.

If you haven’t already, take a closer look tonight — and stay tuned for the morning update.

Sincerely,
Tate Remington
Chief Editor, Market Maven Insights

^{MarketMavenInsights.com}^{(“MarketMavenInsights” or “MMI”) is owned by Source Coastal Media LLC, a multi member limited liability company. Data is provided from third-party sources and MMI is not responsible for its accuracy. Make sure to always do your own research and due diligence on any day and swing profile MMI brings to your attention. Any emojis used do not have a specific defined meaning, and may be used inconsistently. We do not provide personalized in.vest.ment advice, are not in.vest.ment advisors, and any profiles we mention are not suitable for all in.vest.ors.}

^{Pursuant to an agreement between Source Coastal Media LLC and TD Media LLC, Source Coastal Media LLC has been hired for a period beginning on 10/29/2025 and ending on 10/30/2025 to publicly disseminate information about (COSM:US) via digital communications. Under this agreement, Source Coastal Media LLC has been paid five thousand USD (“Funds”). These Funds were part of the funds that TD Media LLC received from a third party who did not receive the Funds directly or indirectly from the Issuer and does not own stock in the Issuer but the reader should assume that the clients of the third party own shares in the Issuer, which they will liquidate at or near the time you receive this communication and has the potential to hurt share prices.}

^{Neither Source Coastal Media LLC, TD Media LLC and their member own shares of (COSM:US).}

^{Please see important disclosure information here:}^{https://marketmaveninsights.com/disclosure/cosm-huljg/#details}

Update your email preferences or unsubscribe here

1691 Forum Place Ste B #332
West Palm Beach, Florida 33401, United States of America

JUST IN: Trump REVERSES REMOVAL – Return SHOCKS D.C.

Trump’s national nightmare is here

RJ Hamster